While it may not be enough for some shareholders, we think it is good to see the TerrAscend Corp. (TSE:TSND) share price up 13% in a single quarter. But will that repair the damage for the weary ...

Transcend Therapeutics has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to TSND-201, a rapid-acting neuroplastogen, for the treatment of ...

Net Revenue totaled $65 million and Gross Profit Margin was 51.1% from continuing operations, excluding Michigan 12th consecutive quarter of positive Cash Flow from continuing operations and 8th ...

What is the current share price of TERRASCEND CORP (TSND)? TERRASCEND CORP's (TSND) current share price is $0.50. This constitutes a price movement of 12.28% when compared to the share price 7 days ...

Primary endpoint met, with TSND-201 demonstrating statistically significant placebo-adjusted CAPS-5 improvement of -9.64 points on Day 64 (p = 0.011) TSND-201 demonstrated rapid improvements, with a ...

TerrAscend Corp. TRSSF TSND commenced trading of its common shares on the Toronto Stock Exchange on July 4th, under the new ticker symbol "TSND." No action is required by shareholders in order to ...

TORONTO, July 04, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TRSSF), a leading North American cannabis company, today announced the commencement of ...

A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company Valuation methodology provided by Stockcalc (see ...

TerrAscend Corp. Annual cash flow by MarketWatch. View TSND net cash flow, operating cash flow, operating expenses and cash dividends.

**NM signifies a non meaningful value. A dash signifies the data is not available.

TSND-201, a rapid-acting neuroplastogen, is a proprietary formulation of methylone developed by Transcend Therapeutics. TSND-201 has well-characterized primary pharmacology, with its primary site of ...

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the appointment of ...